148 related articles for article (PubMed ID: 11298327)
21. Detection of aberrant association of DM with MHC class II subunits in the absence of invariant chain.
Neumann J; König A; Koch N
Int Immunol; 2007 Jan; 19(1):31-9. PubMed ID: 17105964
[TBL] [Abstract][Full Text] [Related]
22. Clip binds to HLA class II using methionine-based, allele-dependent motifs as well as allele-independent supermotifs.
Geluk A; Van Meijgaarden KE; Drijfhout JW; Ottenhoff TH
Mol Immunol; 1995 Sep; 32(13):975-81. PubMed ID: 7477003
[TBL] [Abstract][Full Text] [Related]
23. Expression and function of HLA-DR3 and DQ8 in transgenic mice lacking functional H2-M.
Rajagopalan G; Smart MK; Cheng S; Krco CJ; Johnson KL; David CS
Tissue Antigens; 2003 Aug; 62(2):149-61. PubMed ID: 12889995
[TBL] [Abstract][Full Text] [Related]
24. Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells.
Denzin LK; Robbins NF; Carboy-Newcomb C; Cresswell P
Immunity; 1994 Oct; 1(7):595-606. PubMed ID: 7600288
[TBL] [Abstract][Full Text] [Related]
25. Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM.
Vogt AB; Kropshofer H; Moldenhauer G; Hämmerling GJ
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9724-9. PubMed ID: 8790398
[TBL] [Abstract][Full Text] [Related]
26. The majority of HLA-DR3 alloreactive T cells is peptide specific, but does not recognize known DR3-bound sequences.
de Koster HS; Vermeulen CJ; Koning F
Tissue Antigens; 1998 Jan; 51(1):88-95. PubMed ID: 9459508
[TBL] [Abstract][Full Text] [Related]
27. Multiple signals regulate the intracellular trafficking of HLA-DM in B-lymphoblastoid cells.
Copier J; Potter P; Sacks SH; Kelly AP
Immunology; 1998 Apr; 93(4):505-10. PubMed ID: 9659222
[TBL] [Abstract][Full Text] [Related]
28. Accessory molecules for MHC class II peptide loading.
Busch R; Doebele RC; Patil NS; Pashine A; Mellins ED
Curr Opin Immunol; 2000 Feb; 12(1):99-106. PubMed ID: 10679402
[TBL] [Abstract][Full Text] [Related]
29. Intracellular and cell surface heterotypic associations of human leukocyte antigen-DR and human invariant chain.
Triantafilou K; Triantafilou M; Wilson KM; Cherry RJ; Fernandez N
Hum Immunol; 1999 Nov; 60(11):1101-12. PubMed ID: 10600008
[TBL] [Abstract][Full Text] [Related]
30. Transport and intracellular distribution of MHC class II molecules and associated invariant chain in normal and antigen-processing mutant cell lines.
Riberdy JM; Avva RR; Geuze HJ; Cresswell P
J Cell Biol; 1994 Jun; 125(6):1225-37. PubMed ID: 8207055
[TBL] [Abstract][Full Text] [Related]
31. The CLIP-substituted invariant chain efficiently targets an antigenic peptide to HLA class II pathway in L cells.
Fujii S; Senju S; Chen YZ; Ando M; Matsushita S; Nishimura Y
Hum Immunol; 1998 Oct; 59(10):607-14. PubMed ID: 9757942
[TBL] [Abstract][Full Text] [Related]
32. HLA-DO transduced in human monocyte-derived dendritic cells modulates MHC class II antigen processing.
Bellemare-Pelletier A; Tremblay J; Beaulieu S; Boulassel MR; Routy JP; Massie B; Lapointe R; Thibodeau J
J Leukoc Biol; 2005 Jul; 78(1):95-105. PubMed ID: 15817706
[TBL] [Abstract][Full Text] [Related]
33. Association between HLA-DM and HLA-DR in vivo.
Sanderson F; Thomas C; Neefjes J; Trowsdale J
Immunity; 1996 Jan; 4(1):87-96. PubMed ID: 8574855
[TBL] [Abstract][Full Text] [Related]
34. Unexpected reactivities of T cells selected by a single MHC-peptide ligand.
Singh N; Van Kaer L
J Immunol; 1999 Oct; 163(7):3583-91. PubMed ID: 10490950
[TBL] [Abstract][Full Text] [Related]
35. T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.
Morkowski S; Goldrath AW; Eastman S; Ramachandra L; Freed DC; Whiteley P; Rudensky AYu
J Exp Med; 1995 Nov; 182(5):1403-13. PubMed ID: 7595211
[TBL] [Abstract][Full Text] [Related]
36. MHC class II-associated invariant chain peptide replacement by T cell epitopes: engineered invariant chain as a vehicle for directed and enhanced MHC class II antigen processing and presentation.
Malcherek G; Wirblich C; Willcox N; Rammensee HG; Trowsdale J; Melms A
Eur J Immunol; 1998 May; 28(5):1524-33. PubMed ID: 9603457
[TBL] [Abstract][Full Text] [Related]
37. Quality control of MHC class II associated peptides by HLA-DM/H2-M.
Vogt AB; Arndt SO; Hämmerling GJ; Kropshofer H
Semin Immunol; 1999 Dec; 11(6):391-403. PubMed ID: 10625593
[TBL] [Abstract][Full Text] [Related]
38. Dissection of the HLA-DR4 peptide repertoire in endocrine epithelial cells: strong influence of invariant chain and HLA-DM expression on the nature of ligands.
Muntasell A; Carrascal M; Alvarez I; Serradell L; van Veelen P; Verreck FA; Koning F; Abian J; Jaraquemada D
J Immunol; 2004 Jul; 173(2):1085-93. PubMed ID: 15240697
[TBL] [Abstract][Full Text] [Related]
39. T cell recognition of flanking residues of murine invariant chain-derived CLIP peptide bound to MHC class II.
Naujokas MF; Southwood S; Mathies SJ; Appella E; Sette A; Miller J
Cell Immunol; 1998 Aug; 188(1):49-54. PubMed ID: 9743557
[TBL] [Abstract][Full Text] [Related]
40. Binding of a major T cell epitope of mycobacteria to a specific pocket within HLA-DRw17(DR3) molecules.
Geluk A; Bloemhoff W; De Vries RR; Ottenhoff TH
Eur J Immunol; 1992 Jan; 22(1):107-13. PubMed ID: 1370411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
